Español
PrintEmail
Decrease (-) Restore Default Increase (+)
In This Section Texas Health Research & Education Institute

Clinical Trials

Disease or Condition   Venous Thromboembolism (VTE)
Title   A Safety and Efficacy Trial of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization (Venous Thromboembolism - VTE)
Description   This is a randomized study comparing Lovenox (an FDA approved drug) with Apixaban (an investigational medicine) for acutely ill patients with a high risk of developing a blood clot. This study is 90 days in length.
IRB Number   Pro92
Inclusion/Notes   INCLUSION:
  • Men and non-pregnant, non-brestfeeding women ages 40 years or older.

  • Patients hospitalized with congestive heart failure or acute respiratory failure.

  • Patients with an infection (without septic shock).

  • Patient with acute rheumatoid disorder.

  • Patients with inflammatory bowel disease.

EXCLUSION:
  • Patients with a detected blood clot, pregnant, abnormal liver or kidney blood tests, or who currently require long term anti-coagulation medications are not eligible for this study.

  • Patients who have a bleeding disorder or other serious illnesses may not be eligible to participate.
Status   Terminated
Location   Texas Health Presbyterian Dallas
Principal Name    Gary L Weinstein MD
Contact Name   Claire Peterson, RN, BSCN, CCRC
Phone   (214) 345-4121

Online Tools

Locations

Helpful Info

Links